Global Neurology Academy
The Global Neurology Academy (GNA) series offers certified education modules and video interviews from leading MS experts from across the globe as they address topics such as induction therapy in relapsing-remitting multiple sclerosis; No Evidence of Disease Activity (NEDA) concept; how different agents used in MS management may be utilized in induction therapy; appreciation of how reductions in end-organ damage impact patient quality-of-life; mechanisms of action of the classical as well as emergent agents; key issues associated with making the correct differential diagnosis of multiple sclerosis, in addition to how best to incorporate prognostic indicators into clinical decision-making; current and emergent novel oral agents in MS management; and diagnostic strategies and identifying predictors of outcome.
For more information about GNA, visit www.globalneurologyacademy.org.
106-120 of 232
Challenging Migraine Stereotypes: Improving Patient Care Through Empathy and Insight
On the Frontlines of MigraineChallenging Migraine Stereotypes: Improving Patient Care Through Empathy and Insight
Charles Turck, PharmD, BCPS, BCCCP
Rashmi B. Halker Singh, M.D.
Early Ocrelizumab Intervention in RRMS: Real-World Data Reinforces a Shift in Strategy
NeuroFrontiersEarly Ocrelizumab Intervention in RRMS: Real-World Data Reinforces a Shift in Strategy
Data Equity in Action: Largest Real-World MS Analysis Confirms Fumarate Efficacy Across Racial Groups
NeuroFrontiersData Equity in Action: Largest Real-World MS Analysis Confirms Fumarate Efficacy Across Racial Groups
Intermittent Calorie Restriction Alters Immune and Metabolic Markers in RRMS
NeuroFrontiersIntermittent Calorie Restriction Alters Immune and Metabolic Markers in RRMS
Exploring Circulating CD34+ Cells as a Biomarker of Fracture Risk in DMD
NeuroFrontiersExploring Circulating CD34+ Cells as a Biomarker of Fracture Risk in DMD
Quantifying the Hidden Cost Burden of Duchenne Muscular Dystrophy on U.S. Households
NeuroFrontiersQuantifying the Hidden Cost Burden of Duchenne Muscular Dystrophy on U.S. Households
- advertisement
Cardiopulmonary Exercise Testing Sheds Light on Early Physiologic Decline in Duchenne Muscular Dystrophy
NeuroFrontiersCardiopulmonary Exercise Testing Sheds Light on Early Physiologic Decline in Duchenne Muscular Dystrophy
Assessing Sex-Based Treatment Responses to Gepants In Migraine Management
On the Frontlines of MigraineAssessing Sex-Based Treatment Responses to Gepants In Migraine Management
Prioritizing Patient-Centered, Multidisciplinary Care in CIDP
On the Frontlines of CIDPPrioritizing Patient-Centered, Multidisciplinary Care in CIDP
Andrew G. Lee, MD
Ashley Baker, MSN, PMHNP
Transforming Clinician Wellness: EEG Headphones Helping with Burnout
NeuroFrontiersTransforming Clinician Wellness: EEG Headphones Helping with Burnout
John Golden
Michael Greenberg, MD
Tuning the Brain: Personalized Anxiety Relief with Neurofeedback-Driven Headphones
NeuroFrontiersTuning the Brain: Personalized Anxiety Relief with Neurofeedback-Driven Headphones
John Golden
Michael Greenberg, MD
Identifying CIDP: A Guide to Risk Profiles and Clinical Presentation
On the Frontlines of CIDPIdentifying CIDP: A Guide to Risk Profiles and Clinical Presentation
Nicolas Dubuisson, MD
Ryan Quigley
- advertisement
Optimizing DMD Care Through Multidisciplinary Collaboration
NeuroFrontiersOptimizing DMD Care Through Multidisciplinary Collaboration
Kaitlin Batley, MD
Gene Therapy Safety in DMD: How to Identify Common Immune Reactions
NeuroFrontiersGene Therapy Safety in DMD: How to Identify Common Immune Reactions
Kaitlin Batley, MD
Symptom Control in gMG: Comparing Ravulizumab and Efgartigimod
NeuroFrontiersSymptom Control in gMG: Comparing Ravulizumab and Efgartigimod
Christopher A. Scheiner, MD, PhD
